Next 10 |
home / stock / immvf / immvf news
2024-02-21 12:47:41 ET More on Immunovia Financial information for Immunovia Read the full article on Seeking Alpha For further details see: Immunovia reports Q4 results
2023-11-09 12:09:00 ET More on Immunovia Financial information for Immunovia For further details see: Immunovia reports Q3 results
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
2023-05-01 04:09:40 ET Board of Directors of Immunovia AB ( OTC:IMMVF ) appoints Jeff Borcherding, until now President of Immunovia's US operation, as global CEO. Jeff Borcherding replaces Philipp Matthieu. Jeff Borcherding has led Immunovia's US busin...
Immunovia press release ( OTC:IMMVF ): Q4 GAAP EPS of -SEK2.97. Revenue of SEK502M (+64.6% Y/Y). For further details see: Immunovia GAAP EPS of -SEK2.97, revenue of SEK502M
Immunovia press release ( OTC:IMMVF ): Q3 GAAP EPS of -SEK 1.01. Revenue of SEK 0.36M (-5.3% Y/Y). Cash and equivalents at the end of the period amounted to SEK 159M. For further details see: Immunovia GAAP EPS of -SEK 1.01, revenue of SEK 0.36M
Immunovia (OTCPK:IMMVF) has appointed Philipp Mathieu as Chief Executive Officer and President effective immediately. Since January, Philipp has been acting Chief Executive Officer and President. Most recently, Philipp was a Portfolio Manager and Advisor to a multinational family of...
Immunovia (OTCPK:IMMVF) said the Pennsylvania and Maryland Departments of Health granted its U.S. subsidiary clinical laboratory permits, allowing physicians in the two states to order its pancreatic cancer detection test IMMray PanCan-d test for their patients. We are very hap...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia press release (OTCPK:IMMVF): Q1 GAAP EPS of -SEK 1.95. Revenue of SEK 0.18M (+50.0% Y/Y). For further details see: Immunovia GAAP EPS of -SEK 1.95, revenue of SEK 0.18M
News, Short Squeeze, Breakout and More Instantly...
Immunovia AB Company Name:
IMMVF Stock Symbol:
OTCMKTS Market:
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...